by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

PLZ Corp Warning Letter Details

Warning Letter

PLZ Corp

6080 Vipond Dr. Mississauga ON L5T 2V4 Canada

Issue DateJune 02, 2026

FEI Number3001956890

Violations4

CountryCanada

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/OTC Finished Pharmaceuticals/Adulterated

PLZ Corp FDA Warning Letter, June 2, 2026